CTRI/2021/01/030455进行中（未招募）未知
Seroprevalence of SARS-CoV2 Specific IgG Antibodies Among Blood Donors
ivetha M0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All healthy eligible blood donors who are willing to Participate in the study
排除标准
- •Blood Donors who are not willing to participate in the study.
研究者
相似试验
招募中
不适用
Seroprevalence of anti-SARS-CoV-2 antibody in response to COVID-19 vaccine in patients with i nflammatory bowel diseaseKCT0006901Keimyung University Dongsan Hospital150
已完成
不适用
Seroprevalence of SARS-CoV-2 antibodies among healthcare workers with differing risk of exposureCOVID-1910047438NL-OMON49447niversitair Medisch Centrum Groningen600
招募中
不适用
Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in LeipzigU07.1COVID-19, virus identifiedDRKS00023364Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig2,000
招募中
不适用
SARS-CoV-2-IgG-titer of antibodies in helathcare workers after recovery or vaccinatio07.1 COVID-19DRKS00026288Evangelische Kliniken Gelsenkirchen800
已完成
不适用
Seroprevalence of SARS-CoV-2 antibodies in a quarantined community after a COVID-19 outbreak-the CoNAN study07.1 COVID-19DRKS00022416niversitätsklinikum Jena626